Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjogren's syndrome -: A comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria

被引:41
作者
Locht, H
Pelck, R
Manthorpe, R
机构
[1] Statens Serum Inst, Dept Autoimmunol, DK-2300 Copenhagen, Denmark
[2] Sjogrens Syndrome Res Ctr, SE-21237 Malmo, Sweden
关键词
Sjogren's syndrome; classification criteria; autoantibodies; anti-Ro; anti-La; ANA;
D O I
10.1016/j.autrev.2004.12.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study we imposed the recently described American-European consensus criteria for primary Sjogren's syndrome (pSS) on a large cohort of patients originally classified according to the Copenhagen set of criteria. Of the 321 patients fulfilling the Copenhagen criteria, 205 conformed to the Consensus criteria. When comparing clinical manifestations and laboratory findings between the two groups defined by different standards we found only small variations. Thus, the consequence of using the Consensus criteria in daily clinical practice will lead to the exclusion of a considerable proportion of patients with classical features of pSS. The main reason for this discrepancy is probably the absolute requirement of a positive test for anti-Ro/La or a characteristic lymphocytic infiltration in the labial gland biopsy. The sensitivity and specificity of testing for autoantibodies to Ro-52, Ro-60, and La were calculated for each set of criteria. Antibodies to La but not to Ro-52 or Ro-60 were strongly correlated to internal organ (kidney, lung, liver) dysfunction in pSS (OR 6; 95% Cl 312), p < 0.0001. Although presence of ANA was slightly more prevalent among patients with internal organ involvement it did not reach statistical significance. The fine speckled ANA pattern was most often found followed by the homogeneous and centromere pattern. Individual ANA patterns did not correlate with any particular organ manifestation. (c) 2004 Elsevier B.V All rights reserved.
引用
收藏
页码:276 / 281
页数:6
相关论文
共 25 条
[1]   A new model for classification of disease manifestations in primary Sjogren's syndrome: Evaluation in a retrospective long-term study [J].
Asmussen, K ;
Andersen, V ;
Bendixen, G ;
Schiodt, M ;
Oxholm, P .
JOURNAL OF INTERNAL MEDICINE, 1996, 239 (06) :475-482
[2]   Quantitative assessment of clinical disease status in primary Sjogren's syndrome - A cross-sectional study using a new classification model [J].
Asmussen, K ;
Andersen, V ;
Bendixen, G ;
Bendtzen, K ;
Prause, JU ;
Thorn, J ;
Wiik, A ;
Oxholm, P .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1997, 26 (03) :197-205
[3]   THE LA ANTIGEN SHUTTLES BETWEEN THE NUCLEUS AND THE CYTOPLASM IN CV-1 CELLS [J].
BACHMANN, M ;
PFEIFER, K ;
SCHRODER, HC ;
MULLER, WEG .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1989, 85 (02) :103-114
[4]  
BOIRE G, 1995, CLIN EXP IMMUNOL, V100, P489
[5]  
BOULANGER C, 1995, CLIN EXP IMMUNOL, V99, P29
[6]   Primary Sjogren's syndrome in the North East of England: a long-term follow-up study [J].
Davidson, BKS ;
Kelly, CA ;
Griffiths, ID .
RHEUMATOLOGY, 1999, 38 (03) :245-253
[7]   CLINICAL DIFFERENCES BETWEEN ANA ANTI-ENA POSITIVE OR NEGATIVE PRIMARY SJOGRENS-SYNDROME [J].
FOSSALUZZA, V ;
DEVITA, S .
CLINICAL RHEUMATOLOGY, 1992, 11 (03) :385-387
[8]   ANTI-RO (SS-A) AND ANTI-LA (SS-B) IN PATIENTS WITH SJOGRENS-SYNDROME [J].
HARLEY, JB ;
ALEXANDER, EL ;
BIAS, WB ;
FOX, OF ;
PROVOST, TT ;
REICHLIN, M ;
YAMAGATA, H ;
ARNETT, FC .
ARTHRITIS AND RHEUMATISM, 1986, 29 (02) :196-206
[9]  
Hassan AB, 2002, SCAND J RHEUMATOL, V31, P133
[10]   RO SMALL CYTOPLASMIC RIBONUCLEOPROTEINS ARE A SUBCLASS OF LA RIBONUCLEOPROTEINS - FURTHER CHARACTERIZATION OF THE RO AND LA SMALL RIBONUCLEOPROTEINS FROM UNINFECTED MAMMALIAN-CELLS [J].
HENDRICK, JP ;
WOLIN, SL ;
RINKE, J ;
LERNER, MR ;
STEITZ, JA .
MOLECULAR AND CELLULAR BIOLOGY, 1981, 1 (12) :1138-1149